Tue. 14 May 2024, 4:09pm ET
Benzinga
News
- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))))) today announced an updated version of its clinical decision support platform, QIAGEN Clinical Insight Interpret for NGS molecular profiling of hereditary and somatic diseases, has received the European Union (EU) Technical Documentation Assessment and Quality Management System certificate under the European In Vitro Diagnostic Medical Device Regulation (EU) 2017/746 (IVDR).